問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Chia-Yi Christian Hosptal
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2024-12-12 - 2027-09-01
Condition/Disease
OSA Overweight or Obesity
Test Drug
Orforglipron
Participate Sites4Sites
Recruiting4Sites
2023-07-03 - 2028-07-26
Participate Sites5Sites
Recruiting5Sites
2023-06-01 - 2027-12-31
Participate Sites19Sites
Recruiting19Sites
2023-09-15 - 2025-10-22
overweight and obesity
injection
2022-09-01 - 2025-03-07
2022-11-10 - 2027-11-09
Participate Sites7Sites
Recruiting7Sites
2025-07-01 - 2029-03-07
2022-02-16 - 2026-12-31
Hepatocellular Carcinoma Advanced Hepatocellular Carcinoma
ADI-PEG 20
Participate Sites9Sites
Recruiting9Sites
2021-11-01 - 2025-12-31
Participate Sites6Sites
Recruiting6Sites
2020-09-01 - 2022-08-31
全部
